Monday, June 17, 2019

USFDA for voluntary action by Cadila Healthcare on Ahmedabad SEZ facility

The plant has received an establishment inspection report (EIR). The
EIR report stated that the classification of the facility is VAI, it
added.

https://economictimes.indiatimes.com/industry/healthcare/biotech/pharmaceuticals/usfda-for-voluntary-action-by-cadila-healthcare-on-ahmedabad-sez-facility/articleshow/69825292.cms

No comments:

Post a Comment